Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK MRC (UK Medical Research Council) biobank and stem cells under scrutiny:

This article was originally published in Clinica

Executive Summary

The UK Medical Research Council (MRC) is to stand before the House of Commons' Select Committee for Science and Technology (STC) on December 4 2002 to present evidence of its work and expenditure plans. Among the issues on the agenda are the Biobank and Stem Cell Bank projects (see Clinica No 1024, p 8). The Committee will consider comments on these and other areas of the MRC's work, by November 22. The meeting, which will be open to the public, is part of the ongoing programme of scrutiny of the UK's Research Councils, conducted under the STC's remit to examine the expenditure, policy and administration of the Office of Science and Technology and its associated public bodies.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068323

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel